Forecasting the declining rate of chronic hepatitis-B carrier status at a Taiwanese University: Twenty years after implementation of an universal HBV vaccination program in Taiwan

Chang Gung Medical Journal

Volumn 30, Issue 6, 2007, Pages 521-528

  Su, Fu Hsiung ^a   Huang, Hsiao Yun ^b   Chang, Hong Jer ^c   Jeng, Jin Ju ^b   Liu, Yi Hui ^c   Chen, Chih Dao ^a  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

Epidemiology; HBV; Hepatitis B vaccine; Taiwan; Vaccination program

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ARTICLE; CHRONIC HEPATITIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; FORECASTING; HEPATITIS B; HUMAN; MALE; REGRESSION ANALYSIS; SEX DIFFERENCE; TAIWAN; TIME SERIES ANALYSIS; TREND STUDY; VACCINATION;

ADULT; CARRIER STATE; FEMALE; GOVERNMENT PROGRAMS; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; MALE; MASS IMMUNIZATION; STUDENTS; TAIWAN; TIME FACTORS; UNIVERSITIES; VACCINATION;

EID: 38549102163     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kane MA, Clement J, Hu D. Hepatitis B. In: Jamison DT, Mosley WH, Measham AR, Bobadilla J, eds. Disease Control Priorities in Developing Countries. 1st ed. New York: Oxford University Press, 1993:321.
2. Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999;17:1730-3.
3. Chen DS, Sung JL. Hepatitis B virus infection and chronic liver disease in Taiwan. Acta Hepatogastroenterol 1978;25:423-30.
4. Wu JS, Chen CH, Chiang YH, Lee YC, Lee MH, Ko YC, Hu HT. Hepatitis B virus infection in Taiwan with reference to anti-HBc virus HBsAg and anti-HBs. J Formosan Med Assoc 1980;79:760-7.
5. Sung JL, Chen DS, Lai MY, Yu JY, Wang TH, Wang CY, Lee CY, Chen SH, Ko TM. Epidemiological study of hepatitis B virus infection in Taiwan. Chin J Gastroenterol 1984;1:1-9.
6. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996;276:906-8.
7. Hsu HM, Lu CF, Lee SC, Lin SR, Chen DS. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 1999;179:367-70.
8. Tsen YJ, Chang MY, Hsu HY, Lee CY, Sung JL, Chen DS. Seroprevalence of hepatitis B infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J Med Virol 1991;34:96-9.
9. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336:1855-9.
10. Lin HH, Wang LY, Hu CT, Huang SC, Huang LC, Lin SS, Chiang YM, Liu TT, Chen CL. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after a newborn vaccination program in Taiwan. J Med Virol 2003;69:471-4.
11. Shumway RH, Stoffer DS. Time Series Regression and ARIMA Models. In: Shumway RH, Stoffer DS, eds. Time Series Analysis and Its Applications. 1 st ed. New York: Springer-Verlag, 2000:144-55.
12. Hsu SC, Chang MH, Ni YH, Hsu HY, Lee CY. Horizontal transmission of hepatitis B virus in children. J Pediatr Gastroenterol Nut 1993;16:66-9.
13. Wong WCW, Tsang KK. A mass hepatitis B vaccination programme in Taiwan: its preparation, results and reasons for uncompleted vaccinations. Vaccine 1994;12:229-34.
14. Lin HH, Wu JS, Lu CF, Wong CK. Hepatitis B virus infection among aboriginal children in eastern Taiwan. J Formos Med Assoc 1992;91:691-3.
15. Fang JW, Lai CL, Chung HT, Wu PC, Lau JY. Female children respond to recombinant hepatitis B vaccine with a higher titre than male. J Trop Pediatr 1994;40:104-7.
16. Lin HH, Lin SS, Chiang YM, Chiang YM, Wang LY, Huang LC, Huang SC, Liu TT. Trend of hepatitis B virus infection in freshmen classes at two high schools in Hualien, Taiwan from 1991 to 1999. J Med Virol 2002;67:472-6.
17. Lu SN, Chen CH, Chen TM, Lee PL, Wang JH, Tung HD, Hung CH, Lee CM, Changchien CS. Hepatitis B virus infection in adolescents in a rural township - 15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 2006;24:759-65.
18. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001;135:796-800.
19. Department of Health. Public Health in Taiwan, Republic of China. The Executive Yuan 1998;2:57-9.
20. Coursaget P, Yvonnet B, Chotard J, Sarr M, Vincelot P, N'doye R, Diop-Mar I, Chiron JP. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet 1986;2:1143-5.
21. Poovorawan Y, Sanpavat S, Chumdermpadetsuk S, Safary A. Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers. Arch Dis Child Fetal Neonatal Ed 1997;77:F47-51.
22. Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, Twu SJ, Su IJ, Huang LM, Lee CY. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004;40:1415-20.
23. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, Khristova M, Zanis C, Peters H, Margolis HS. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow up. Ann Intern Med 2005;142:333-41.
24. Zuckerman AJ. Prevention of primary liver cancer by immunization. N Engl J Med 1997;336:1906-7.